Factitious anticoagulant-resistance as a cause of recurrent arterial bypass graft occlusions

Beate Luxembourg; Helen Mani; Stefan W. Toennes; Gerson Strubel; Christina Klaeffling; Gabriele Daemgen-von Brevern; Christof Geisen; Edelgard Lindhoff-Last

doi:10.1160/TH06-10-0600

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2007; 97(06): 1046-1048
DOI: 10.1160/TH06-10-0600

Case Report

Schattauer GmbH

Factitious anticoagulant-resistance as a cause of recurrent arterial bypass graft occlusions

Beate Luxembourg

¹Department of Internal Medicine, Division of Vascular Medicine, University Hospital Frankfurt am Main, Germany

,

Helen Mani

¹Department of Internal Medicine, Division of Vascular Medicine, University Hospital Frankfurt am Main, Germany

,

Stefan W. Toennes

²Institute of Forensic Toxicology, Center of Legal Medicine, University Hospital Frankfurt am Main, Germany

,

Gerson Strubel

⁴Vascular Medicine, Neustadt, Germany

,

Christina Klaeffling

¹Department of Internal Medicine, Division of Vascular Medicine, University Hospital Frankfurt am Main, Germany

,

Gabriele Daemgen-von Brevern

¹Department of Internal Medicine, Division of Vascular Medicine, University Hospital Frankfurt am Main, Germany

,

Christof Geisen

³Institute of Transfusion Medicine and Immunohaematology, DRK Blood Donor Service Baden-Württemberg-Hessen, Frankfurt am Main, Germany

,

Edelgard Lindhoff-Last

¹Department of Internal Medicine, Division of Vascular Medicine, University Hospital Frankfurt am Main, Germany

› Author Affiliations

Abstract

Full Text

References

References
1 Clagett GP, Sobel M, Jackson MR. et al Antithrombotic therapy in peripheral arterial occlusive disease. Chest 2004; 126: 609S-626S.
2 Rost S, Fregin A, Ivaskevicius V. et al Mutations in VKORC1 cause warfarin resistance and multiple factor deficiency type 2. Nature 2004; 427: 537-541.
3 Geisen C, Watzka M, Sittinger K. et al VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation. Thromb Haemost 2005; 94: 773-779.
4 Szczeklik A, Musial J, Undas A. et al Aspirin resistance. J Thromb Haemost 2005; 3: 1655-1662.
5 Hughes DA, Bagust A, Haycox A. et al The impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature. Health Econ 2001; 10: 601-615.
6 Zahner J, Schneider W. Munchausen syndrome in hematology: case reports of three variants and review of the literature. Ann Hematol 1994; 68: 303-306.
7 Chua JD, Friedenberg WR. Superwarfarin poisoning. Arch Intern Med 1998; 158: 1929-1932.
8 Eckhardt-Henn A. Factitious disorders and Munchausens`s syndrome. The state of research. Psychother Psychosom Med Psychol 1999; 49: 75-89.
9 Croft PR, Racz MI, Bloch JD. et al Autopsy confirmation of severe pulmonary interstitial fibrosis secondary to Munchausen syndrome presenting as cystic fibrosis. J Forensic Sci 2005; 50: 1194-8.
10 de Fontaine S, Van Geertruyden J, Preud'homme X. et al Munchausen syndrome. Ann Plast Surg 2001; 46: 153-158.
11 Park TA, Borsch MA, Dyer AR. et al Cardiopathia fantastica: the cardiac variant of Munchausen syndrome. South Med J 2004; 97: 48-52.
12 Ehsan O, Darwish A, Edmundson C. et al Nontraumatic lower limb vascular complications in endurance athletes. Review of literature. Eur J Vasc Endovasc Surg 2004; 28: 1-8.
13 Krahn LE, Li H, O'Connor MK. Patients who strive to be ill: factitious disorder with physical symptoms. Am J Psychiatry 2003; 160: 1163-1168.
14 Villanueva RB, Brett E, Gabrilove JL. A cluster or cases of factitious Cushing`s syndrome. Endocr Pract 2000; 6: 143-147.